Ultime notizie per Profound Medical (NASDAQ:PROF) Azioni

Profound Medical

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

News

Press Releases

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Profound Medical Corp. - PROF

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Earnings

Profound Medical Announces First Quarter 2025 Financial Results

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

Health Care

General

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

Comments

Profound Medical

Notizie

Ultime notizie per Profound Medical (NASDAQ:PROF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO